KRX-0502

DRUG2 trials

Sponsors

Keryx Biopharmaceuticals

Conditions

Anemia of Chronic Kidney DiseaseChronic Kidney DiseasesIron Deficiency Anemia

Phase 2

A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia

CompletedNCT02128074

Keryx BiopharmaceuticalsAnemia of Chronic Kidney Disease

Start: 2014-04-30End: 2014-11-30Updated: 2018-08-24

Phase 4

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

CompletedNCT03236246

Keryx BiopharmaceuticalsChronic Kidney Diseases, Iron Deficiency Anemia

Start: 2017-08-15End: 2019-09-27Updated: 2021-03-12

Related Papers

SO050DIFFERENT FERRIC CITRATE DOSE REGIMENS IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CKD: THE COMPASS TRIAL

Nephrology Dialysis Transplantation2020-06-01